
WuXi Biologics (Cayman) Inc
HKEX:2269

Wall Street
Price Targets
Price Targets Summary
WuXi Biologics (Cayman) Inc
According to Wall Street analysts, the average 1-year price target for
WuXi Biologics (Cayman) Inc
is 29.03 HKD
with a low forecast of 10.1 HKD and a high forecast of 47.25 HKD.
Operating Income
Forecast
Operating Income Estimate
WuXi Biologics (Cayman) Inc
For the last 8 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's operating income is
46%.
The projected
CAGR
for the next 3 years is
19%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
29.03
HKD
According to Wall Street analysts, the average 1-year price target for
WuXi Biologics (Cayman) Inc
is 29.03 HKD
with a low forecast of 10.1 HKD and a high forecast of 47.25 HKD.
What is WuXi Biologics (Cayman) Inc's Revenue forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's revenue is
44%.
The projected
CAGR
for the next 3 years is
15%.
What is WuXi Biologics (Cayman) Inc's Operating Income forecast?
Projected CAGR
19%
For the last 8 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's operating income is
46%.
The projected
CAGR
for the next 3 years is
19%.
What is WuXi Biologics (Cayman) Inc's Net Income forecast?
Projected CAGR
22%
For the last 8 years the
compound annual growth rate for
WuXi Biologics (Cayman) Inc's net income is
49%.
The projected
CAGR
for the next 3 years is
22%.